DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Chow LW, Yip AY, Chu WP et al.
Bone metabolism and quality-of-life of postmenopausal women with invasive breast cancer receiving neoadjuvant hormonal therapy: sub-analyses from celecoxib anti-aromatase neoadjuvant (CAAN) trial.
J Steroid Biochem Mol Biol 2011;
125: 112-119
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.